Anavex Life Sciences Corp (AVXL)

[Gator328]

My guess is we get an update mid-December. I’m basing this on the FDA wanting to get a lot of its administrative housekeeping finished before 2022.

I don’t expect any news to include an Alzheimer’s sneak peek at the data. That would be a terrible long-term strategy.

My gut is that we see Rett approval in late 2022 and use the priority review voucher to accelerate an FDA decision right around the time the Alzheimer’s data should become available.